How would you manage metastatic alveolar soft part sarcoma in an young patient failing TKI?

I am going to assume that the patient has either progressive or symptomatic disease, or at least a legitimate concern for any impending complication/s requiring therapy. There is clearly an emerging body of data, presented and published, supporting activity of checkpoint inhibitors in ASPS. Prelimin...